首页 > 最新文献

Journal of thoracic disease最新文献

英文 中文
The role of pleural pressure in inducing pneumothorax and other adverse effects of positive pressure ventilation. 胸膜压力在诱发气胸方面的作用以及正压通气的其他不良影响。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-30 Epub Date: 2024-11-18 DOI: 10.21037/jtd-24-497
Jan van Egmond, Leo H D J Booij

Mechanical ventilation, essential for critically ill patients, contrasts with natural respiration, primarily due to differences in pleural pressure (Ppleural ). Natural inspiration decreases Ppleural , pulling the lungs away from the thoracic wall, whereas positive pressure inspiration increases Ppleural , pushing the lungs against the thoracic wall. This shift has several consequences. First, elevated Ppleural during positive pressure ventilation can lead to cyclic airway closure, particularly in the dependent lung regions. This increases the risk of atelectasis, that impairs oxygenation and may lead to further complications such as pneumonia. Second, the increase in Ppleural disrupts the balance maintained by negative Ppleural and capillary forces. This disruption reduces the lubricating pleural fluid between the pleurae, increasing friction and shear stress on the lung tissues, which may lead to damage and conditions such as ventilator-induced lung injury and pneumothorax. Furthermore, airway closure can worsen lung compliance, making mechanical ventilation more challenging and increasing the risk of lung overstretching. This necessitates careful management of ventilation settings, particularly the use of positive end-expiratory pressure (PEEP) and recruitment maneuvers to minimize these adverse effects. Protective strategies, such as synchronizing mechanical ventilation with the patient's breathing efforts, prone positioning, and careful application of PEEP, are crucial in reducing Ppleural and its associated risks. Since negative pressure ventilation (NPV) inherently lowers Ppleural , it may help avoid many of the adverse side effects previously discussed. Therefore, reconsidering and reintroducing NPV in a modern context should be seriously explored.

机械通气对重症患者至关重要,它与自然呼吸形成鲜明对比,主要是因为胸膜压力(Ppleural)不同。自然吸气会降低胸膜压力,将肺部拉离胸壁,而正压吸气会增加胸膜压力,将肺部推向胸壁。这种变化会产生几种后果。首先,正压通气时胸廓气压升高会导致气道周期性关闭,尤其是在依附肺区域。这增加了发生肺不张的风险,从而影响氧合,并可能导致肺炎等并发症。其次,胸膜压力的增加会破坏由胸膜负压和毛细血管力维持的平衡。这种破坏会减少胸膜间的润滑性胸液,增加肺组织的摩擦和剪切应力,从而可能导致呼吸机诱发的肺损伤和气胸等损伤和病症。此外,气道关闭会恶化肺顺应性,使机械通气更具挑战性,并增加肺过度扩张的风险。这就需要对通气设置进行仔细管理,尤其是使用呼气末正压(PEEP)和吸入操作,以尽量减少这些不良影响。保护性策略,如使机械通气与患者的呼吸努力同步、俯卧位和谨慎使用 PEEP,对于减少胸膜腔积液及其相关风险至关重要。由于负压通气 (NPV) 本身可以降低胸膜腔压力,因此可以帮助避免之前讨论过的许多不良副作用。因此,在现代情况下重新考虑和重新引入负压通气应该认真探讨。
{"title":"The role of pleural pressure in inducing pneumothorax and other adverse effects of positive pressure ventilation.","authors":"Jan van Egmond, Leo H D J Booij","doi":"10.21037/jtd-24-497","DOIUrl":"10.21037/jtd-24-497","url":null,"abstract":"<p><p>Mechanical ventilation, essential for critically ill patients, contrasts with natural respiration, primarily due to differences in pleural pressure (<i>P<sub>pleural</sub></i> ). Natural inspiration decreases <i>P<sub>pleural</sub></i> , pulling the lungs away from the thoracic wall, whereas positive pressure inspiration increases <i>P<sub>pleural</sub></i> , pushing the lungs against the thoracic wall. This shift has several consequences. First, elevated <i>P<sub>pleural</sub></i> during positive pressure ventilation can lead to cyclic airway closure, particularly in the dependent lung regions. This increases the risk of atelectasis, that impairs oxygenation and may lead to further complications such as pneumonia. Second, the increase in <i>P<sub>pleural</sub></i> disrupts the balance maintained by negative <i>P<sub>pleural</sub></i> and capillary forces. This disruption reduces the lubricating pleural fluid between the pleurae, increasing friction and shear stress on the lung tissues, which may lead to damage and conditions such as ventilator-induced lung injury and pneumothorax. Furthermore, airway closure can worsen lung compliance, making mechanical ventilation more challenging and increasing the risk of lung overstretching. This necessitates careful management of ventilation settings, particularly the use of positive end-expiratory pressure (PEEP) and recruitment maneuvers to minimize these adverse effects. Protective strategies, such as synchronizing mechanical ventilation with the patient's breathing efforts, prone positioning, and careful application of PEEP, are crucial in reducing <i>P<sub>pleural</sub></i> and its associated risks. Since negative pressure ventilation (NPV) inherently lowers <i>P<sub>pleural</sub></i> , it may help avoid many of the adverse side effects previously discussed. Therefore, reconsidering and reintroducing NPV in a modern context should be seriously explored.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"8103-8109"},"PeriodicalIF":2.1,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142828978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A predictive nomogram for EGFR mutation status in lung adenocarcinoma manifesting as ground-glass nodules. 表现为磨玻璃结节的肺腺癌表皮生长因子受体突变状态的预测提名图。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-30 Epub Date: 2024-11-18 DOI: 10.21037/jtd-24-1166
Xiaoxia Ping, Qian Meng, Nan Jiang, Su Hu

Background: The mutation status of epidermal growth factor receptor (EGFR) in lung adenocarcinoma is significantly associated with postoperative progression-free survival. Computed tomography (CT)-based radiomics analysis may have potential value in predicting EGFR mutation status. This study aims to explore the predictive capacity of radiomics analysis for EGFR mutation status in lung adenocarcinomas presenting as ground-glass nodules (GGNs).

Methods: We included 199 GGNs confirmed by histopathology from 2016 to 2020. The clinical factors and radiographic characteristics were counted and evaluated. All GGNs were manually delineated and the radiomics features were extracted, using the least absolute shrinkage and selection operator for feature selection. Then the radiographic, radiomics, and combined nomogram model were constructed respectively, and compared with each other. Decision curve analysis (DCA) was used to assess the clinical usefulness of the models, while receiver operating characteristic curves and calibration curves were used to evaluate their predictive performance.

Results: Univariate analysis revealed five variables that were significantly different between the EGFR mutant and wild-type groups. Fifteen radiomics features were significantly associated with EGFR mutations. Among the three models, both the radiomics [area under the curve (AUC) =0.818] and the nomogram (AUC =0.820) had good discriminatory ability in predicting EGFR mutation status and performed consistently in the validation cohort (AUC =0.805, and 0.833, respectively), with higher predictive performance than the radiographic model. The DCA showed that when it comes to EGFR mutation status prediction, the nomogram and the radiomics model showed better overall net benefit than the radiographic model.

Conclusions: For preoperatively predicting the status of EGFR mutation in lung adenocarcinomas manifesting as GGNs, the CT-based radiomics analysis will be valuable.

背景:肺腺癌中表皮生长因子受体(EGFR)的突变状态与术后无进展生存期密切相关。基于计算机断层扫描(CT)的放射组学分析在预测表皮生长因子受体突变状态方面可能具有潜在价值。本研究旨在探索放射组学分析对表现为磨玻璃结节(GGNs)的肺腺癌的表皮生长因子受体突变状态的预测能力:我们纳入了2016年至2020年经组织病理学证实的199例GGN。统计并评估了临床因素和放射学特征。使用最小绝对收缩和选择算子进行特征选择,人工划定所有 GGN 并提取放射组学特征。然后分别构建了放射学模型、放射组学模型和组合提名图模型,并进行了比较。决策曲线分析(DCA)用于评估模型的临床实用性,接收者操作特征曲线和校准曲线用于评估模型的预测性能:单变量分析显示,表皮生长因子受体突变组和野生型组之间有五个变量存在显著差异。15个放射组学特征与表皮生长因子受体突变明显相关。在三种模型中,放射组学模型[曲线下面积(AUC)=0.818]和提名图(AUC=0.820)在预测表皮生长因子受体突变状态方面具有良好的鉴别能力,在验证队列中表现一致(AUC分别为0.805和0.833),预测性能高于放射学模型。DCA显示,在表皮生长因子受体突变状态预测方面,提名图和放射组学模型的总体净效益优于放射摄影模型:结论:对于术前预测表现为GGN的肺腺癌的表皮生长因子受体突变状态,基于CT的放射组学分析将很有价值。
{"title":"A predictive nomogram for <i>EGFR</i> mutation status in lung adenocarcinoma manifesting as ground-glass nodules.","authors":"Xiaoxia Ping, Qian Meng, Nan Jiang, Su Hu","doi":"10.21037/jtd-24-1166","DOIUrl":"10.21037/jtd-24-1166","url":null,"abstract":"<p><strong>Background: </strong>The mutation status of epidermal growth factor receptor (<i>EGFR</i>) in lung adenocarcinoma is significantly associated with postoperative progression-free survival. Computed tomography (CT)-based radiomics analysis may have potential value in predicting <i>EGFR</i> mutation status. This study aims to explore the predictive capacity of radiomics analysis for <i>EGFR</i> mutation status in lung adenocarcinomas presenting as ground-glass nodules (GGNs).</p><p><strong>Methods: </strong>We included 199 GGNs confirmed by histopathology from 2016 to 2020. The clinical factors and radiographic characteristics were counted and evaluated. All GGNs were manually delineated and the radiomics features were extracted, using the least absolute shrinkage and selection operator for feature selection. Then the radiographic, radiomics, and combined nomogram model were constructed respectively, and compared with each other. Decision curve analysis (DCA) was used to assess the clinical usefulness of the models, while receiver operating characteristic curves and calibration curves were used to evaluate their predictive performance.</p><p><strong>Results: </strong>Univariate analysis revealed five variables that were significantly different between the <i>EGFR</i> mutant and wild-type groups. Fifteen radiomics features were significantly associated with <i>EGFR</i> mutations. Among the three models, both the radiomics [area under the curve (AUC) =0.818] and the nomogram (AUC =0.820) had good discriminatory ability in predicting <i>EGFR</i> mutation status and performed consistently in the validation cohort (AUC =0.805, and 0.833, respectively), with higher predictive performance than the radiographic model. The DCA showed that when it comes to <i>EGFR</i> mutation status prediction, the nomogram and the radiomics model showed better overall net benefit than the radiographic model.</p><p><strong>Conclusions: </strong>For preoperatively predicting the status of <i>EGFR</i> mutation in lung adenocarcinomas manifesting as GGNs, the CT-based radiomics analysis will be valuable.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7477-7489"},"PeriodicalIF":2.1,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142828993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A single-center retrospective study of the molecular epidemiological characteristics of different Klebsiella pneumoniae infections in northern China. 关于中国北方不同肺炎克雷伯菌感染分子流行病学特征的单中心回顾性研究。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-30 Epub Date: 2024-11-29 DOI: 10.21037/jtd-24-1148
Wei Chen, Zhao Cai, Shuangqing Liu, Giovanni Sotgiu, Ignacio Martin-Loeches, Yang Cao

Background: Klebsiella pneumoniae (K. pneumoniae) is an opportunistic pathogen that can cause multiple life-threatening infections. Recently, there has been an upward trend in carbapenem-resistant K. pneumoniae infections in China. This epidemiological trend needs to be examined to enable better disease control. We sought to analyze the genomic characteristics, including the prevalent sequence type (ST), resistance, virulence, and evolutionary relationship, of K. pneumoniae strains isolated from patients with different types of infections in northern China to provide theoretical support for the effective prevention and control of the evolution and transmission of K. pneumoniae.

Methods: The STs were analyzed using multi-locus sequence typing (MLST). Drug susceptibility tests were used to examine the resistance of these STs to various antibiotics. A phylogenetic tree of these isolates was constructed using the National Center for Biotechnology Information genome as the reference. Antibiotic resistance genes were identified by comparing the genomic sequences against those in the Comprehensive Antibiotic Resistance Database. Virulence genes were identified using the Virulence Factor database, while the pathogenicity of the isolates was predicted using PathogenFinder.

Results: In total, 38 clinical isolates of K. pneumoniae were identified and sequenced by high-throughput sequencing. Multidrug-resistant ST11 and hypervirulent ST23 were found to be the prevalent K. pneumoniae strains. The distribution of the ST11 strains was strongly correlated with stays in the neurosurgery department (chi square test, P=0.02), while the ST23 strains were more frequently isolated from patients with liver abscesses and gallbladder infections. The ST23 strains were significantly more pathogenic than the other STs (Wilcox test, P<0.001). The resistance analysis showed that the rmtB genes were significantly correlated with amikacin resistance (P<2.2e-16, R2=1). The ST11 strains were also found to co-harbor the KPC-2, rmtB, and TEM-1 genes. To the best of our knowledge, this is the first study to report on the dissemination of such multidrug-resistant K. pneumoniae ST11 strains in Tianjin.

Conclusions: The carbapenem-resistant K. pneumoniae (CRKP) ST11 may become highly virulent K. pneumoniae (CR-hvKP) due to the acquisition of virulence plasmids. Attention should be paid to the evolutionary pressure of a caused by the overuse of antibiotics, which may trigger the further development of multidrug-resistant K. pneumoniae infections.

背景:肺炎克雷伯菌(K. pneumoniae)是一种机会性病原体,可引起多种危及生命的感染。最近,中国耐碳青霉烯类的肺炎克雷伯菌感染呈上升趋势。为了更好地控制疾病,需要对这一流行病学趋势进行研究。我们试图分析从中国北方不同类型感染患者中分离出的肺炎克雷伯菌株的基因组特征,包括流行序列类型(ST)、耐药性、毒力和进化关系,为有效预防和控制肺炎克雷伯菌的进化和传播提供理论支持:方法:采用多焦点序列分型(MLST)对 STs 进行分析。方法:采用多焦点序列分型法(MLST)对STs进行分析,并通过药敏试验检测STs对各种抗生素的耐药性。以美国国家生物技术信息中心基因组为参考,构建了这些分离物的系统发生树。通过将基因组序列与抗生素耐药性综合数据库(Comprehensive Antibiotic Resistance Database)中的序列进行比较,确定了抗生素耐药性基因。利用病毒因子数据库鉴定了病毒性基因,并利用 PathogenFinder 预测了分离物的致病性:结果:通过高通量测序,共鉴定并测序了 38 株肺炎克雷伯菌临床分离株。发现耐多药 ST11 和高病毒性 ST23 是肺炎克雷伯菌的主要菌株。ST11菌株的分布与神经外科的住院时间密切相关(卡方检验,P=0.02),而ST23菌株则更多地从肝脓肿和胆囊感染患者中分离出来。ST23 菌株的致病性明显高于其他 STs(Wilcox 检验,PrmtB 基因与阿米卡星耐药性显著相关(P2=1)。此外,还发现 ST11 菌株共同携带 KPC-2、rmtB 和 TEM-1 基因。据我们所知,这是第一份关于耐多药肺炎克菌 ST11 菌株在天津传播的研究报告:结论:耐碳青霉烯类药物的肺炎克雷伯菌(CRKP)ST11可能因获得毒力质粒而成为高毒力肺炎克雷伯菌(CR-hvKP)。应注意过度使用抗生素造成的进化压力,这可能会引发耐多药肺炎克菌感染的进一步发展。
{"title":"A single-center retrospective study of the molecular epidemiological characteristics of different <i>Klebsiella pneumoniae</i> infections in northern China.","authors":"Wei Chen, Zhao Cai, Shuangqing Liu, Giovanni Sotgiu, Ignacio Martin-Loeches, Yang Cao","doi":"10.21037/jtd-24-1148","DOIUrl":"10.21037/jtd-24-1148","url":null,"abstract":"<p><strong>Background: </strong><i>Klebsiella</i> <i>pneumoniae</i> (<i>K.</i> <i>pneumoniae</i>) is an opportunistic pathogen that can cause multiple life-threatening infections. Recently, there has been an upward trend in carbapenem-resistant <i>K.</i> <i>pneumoniae</i> infections in China. This epidemiological trend needs to be examined to enable better disease control. We sought to analyze the genomic characteristics, including the prevalent sequence type (ST), resistance, virulence, and evolutionary relationship, of <i>K.</i> <i>pneumoniae</i> strains isolated from patients with different types of infections in northern China to provide theoretical support for the effective prevention and control of the evolution and transmission of <i>K.</i> <i>pneumoniae</i>.</p><p><strong>Methods: </strong>The STs were analyzed using multi-locus sequence typing (MLST). Drug susceptibility tests were used to examine the resistance of these STs to various antibiotics. A phylogenetic tree of these isolates was constructed using the National Center for Biotechnology Information genome as the reference. Antibiotic resistance genes were identified by comparing the genomic sequences against those in the Comprehensive Antibiotic Resistance Database. Virulence genes were identified using the Virulence Factor database, while the pathogenicity of the isolates was predicted using PathogenFinder.</p><p><strong>Results: </strong>In total, 38 clinical isolates of <i>K.</i> <i>pneumoniae</i> were identified and sequenced by high-throughput sequencing. Multidrug-resistant ST11 and hypervirulent ST23 were found to be the prevalent <i>K.</i> <i>pneumoniae</i> strains. The distribution of the ST11 strains was strongly correlated with stays in the neurosurgery department (chi square test, P=0.02), while the ST23 strains were more frequently isolated from patients with liver abscesses and gallbladder infections. The ST23 strains were significantly more pathogenic than the other STs (Wilcox test, P<0.001). The resistance analysis showed that the <i>rmtB</i> genes were significantly correlated with amikacin resistance (P<2.2e-16, R<sup>2</sup>=1). The ST11 strains were also found to co-harbor the KPC-2, <i>rmtB</i>, and TEM-1 genes. To the best of our knowledge, this is the first study to report on the dissemination of such multidrug-resistant <i>K.</i> <i>pneumoniae</i> ST11 strains in Tianjin.</p><p><strong>Conclusions: </strong>The carbapenem-resistant <i>K.</i> <i>pneumoniae</i> (CRKP) ST11 may become highly virulent <i>K.</i> <i>pneumoniae</i> (CR-hvKP) due to the acquisition of virulence plasmids. Attention should be paid to the evolutionary pressure of a caused by the overuse of antibiotics, which may trigger the further development of multidrug-resistant <i>K.</i> <i>pneumoniae</i> infections.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7739-7750"},"PeriodicalIF":2.1,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635258/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142828998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of a whole lung lavage program for artificial stone silicosis. 人工石矽肺全肺灌洗计划的有效性和安全性。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-30 Epub Date: 2024-11-29 DOI: 10.21037/jtd-24-1050
Hayley Barnes, David Pilcher, Julia Coull, Jesselyn Sin, Eli Dabscheck, Miranda Siemienowicz, Janu Pirakalathanan, Jun Khoo, Duncan Sweeney, Catriona McLean, Piraveen Pirakalathanan, Nina Eikelis, Christina Begka, Glen Westall, Ryan Hoy

Background: The incidence of silicosis has increased due to occupational silica exposure from artificial stone, with no treatments proven to halt or reverse the disease. Whole lung lavage (WLL) involves the instillation of fluid into the lungs to wash out silica particles and disease-causing inflammatory cells. This study aimed to determine the feasibility, safety, and possible benefit of WLL in patients with artificial stone silicosis.

Methods: In this prospective observational study, people with progressive silicosis with ground glass predominant radiological changes underwent WLL. High resolution computed tomography (HRCT) chest, X-ray velocimetry (XV), lung function tests, forced oscillation technique (FOT), and cardiopulmonary exercise tests (CPET) were performed before and six months after the procedure.

Results: Eight patients underwent WLL between June 2021 and November 2022. Five participants had an improvement in the International Classification of High Resolution Computed Tomography for Occupational and Environmental Respiratory Diseases (ICOERD) CT scores and reduction in XV regional ventilation distribution pre- and six months post-WLL. There was no difference in lung function [annualized rate of change in forced vital capacity (FVC) % predicted mean difference (MD) 1.81; 95% CI: -1.53 to 5.15, P=0.27; forced expiratory volume in 1 second (FEV1) % predicted MD -1.13, 95% CI: -5.08 to 2.83, P=0.55; diffusing capacity for carbon monoxide (DLCO) % predicted MD -2.62, 95% CI: -10.04 to 4.80, P=0.46]. There was no significant difference in CPET or FOT measurements. Following WLL, all patients experienced transient throat discomfort, one had fever and two required oral antibiotics. There were no serious adverse events.

Conclusions: WLL for artificial stone silicosis is safe in an expert centre who has experience in performing WLL in this population, and there may be limited benefit in selected patients. Further research is required to select those who will derive the most benefit.

背景:矽肺病的发病率因职业性接触人造石中的二氧化硅而上升,但没有任何治疗方法被证实能阻止或逆转这种疾病。全肺灌洗(WLL)是指向肺部灌注液体,以洗掉二氧化硅颗粒和致病的炎症细胞。本研究旨在确定人工结石矽肺患者接受全肺灌洗的可行性、安全性和可能的益处:在这项前瞻性观察研究中,患有以磨碎玻璃为主的进行性矽肺的患者接受了 WLL 治疗。术前和术后六个月进行了胸部高分辨率计算机断层扫描(HRCT)、X 射线测速(XV)、肺功能测试、强迫振荡技术(FOT)和心肺运动测试(CPET):八名患者在 2021 年 6 月至 2022 年 11 月期间接受了 WLL。五名参与者的国际职业与环境呼吸疾病高分辨率计算机断层扫描(ICOERD)CT评分有所改善,XV区域通气分布在WLL术前和术后六个月有所减少。肺功能无差异[强迫肺活量(FVC)预测平均差值%的年化变化率(MD)为 1.81;95% CI:-1.53 至 5.15,P=0.27;1 秒用力呼气容积(FEV1)预测平均差值%的年化变化率(MD)为-1.13,95% CI:-5.08 至 2.83,P=0.55;一氧化碳弥散容量(DLCO)预测平均差值%的年化变化率(MD)为-2.62,95% CI:-10.04 至 4.80,P=0.46]。CPET 和 FOT 测量结果无明显差异。WLL后,所有患者均出现短暂的咽喉不适,一人发烧,两人需要口服抗生素。没有出现严重的不良反应:人工结石性矽肺的WLL治疗在有经验的专家中心是安全的,对特定患者可能有有限的益处。需要进一步开展研究,以筛选出受益最大的患者。
{"title":"Efficacy and safety of a whole lung lavage program for artificial stone silicosis.","authors":"Hayley Barnes, David Pilcher, Julia Coull, Jesselyn Sin, Eli Dabscheck, Miranda Siemienowicz, Janu Pirakalathanan, Jun Khoo, Duncan Sweeney, Catriona McLean, Piraveen Pirakalathanan, Nina Eikelis, Christina Begka, Glen Westall, Ryan Hoy","doi":"10.21037/jtd-24-1050","DOIUrl":"10.21037/jtd-24-1050","url":null,"abstract":"<p><strong>Background: </strong>The incidence of silicosis has increased due to occupational silica exposure from artificial stone, with no treatments proven to halt or reverse the disease. Whole lung lavage (WLL) involves the instillation of fluid into the lungs to wash out silica particles and disease-causing inflammatory cells. This study aimed to determine the feasibility, safety, and possible benefit of WLL in patients with artificial stone silicosis.</p><p><strong>Methods: </strong>In this prospective observational study, people with progressive silicosis with ground glass predominant radiological changes underwent WLL. High resolution computed tomography (HRCT) chest, X-ray velocimetry (XV), lung function tests, forced oscillation technique (FOT), and cardiopulmonary exercise tests (CPET) were performed before and six months after the procedure.</p><p><strong>Results: </strong>Eight patients underwent WLL between June 2021 and November 2022. Five participants had an improvement in the International Classification of High Resolution Computed Tomography for Occupational and Environmental Respiratory Diseases (ICOERD) CT scores and reduction in XV regional ventilation distribution pre- and six months post-WLL. There was no difference in lung function [annualized rate of change in forced vital capacity (FVC) % predicted mean difference (MD) 1.81; 95% CI: -1.53 to 5.15, P=0.27; forced expiratory volume in 1 second (FEV1) % predicted MD -1.13, 95% CI: -5.08 to 2.83, P=0.55; diffusing capacity for carbon monoxide (DLCO) % predicted MD -2.62, 95% CI: -10.04 to 4.80, P=0.46]. There was no significant difference in CPET or FOT measurements. Following WLL, all patients experienced transient throat discomfort, one had fever and two required oral antibiotics. There were no serious adverse events.</p><p><strong>Conclusions: </strong>WLL for artificial stone silicosis is safe in an expert centre who has experience in performing WLL in this population, and there may be limited benefit in selected patients. Further research is required to select those who will derive the most benefit.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7630-7639"},"PeriodicalIF":2.1,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesenchymal stem cell treatment alleviates seawater drowning induced lung injury by inhibiting the TNFα/Snail/EMT pathway. 间充质干细胞治疗通过抑制 TNFα/Snail/EMT 通路减轻海水溺水诱发的肺损伤。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-30 Epub Date: 2024-11-25 DOI: 10.21037/jtd-24-1471
Jinxia Liu, Lingping Zhao, Chunsun Li, Yali Jia, Zhen Yang, Zhixin Liang, Haiyang Wang, Xiuqing Ma, Chengcheng Su, Jiabo Ren, Zhenfei Mo, Wenli Liu, Peixin Wu, Yue Yin, Shangshu Liu, Wen Yue, Jiafei Xi, Liangan Chen

Background: Seawater drowning (SWD) has been an escalating hazard in recent years. It can not only cause immediate death but can also inflict severe complications, such as acute lung injury (ALI), which greatly increases the mortality rate. Thus, investigating the mechanism of SWD induced lung injury and discovering effective treatments is of great importance. The aim of this study was to minimize the lethality and disability of SWD-ALI.

Methods: Using male C57BL/6 mice, we established a SWD induced ALI (SWD-ALI) model via the oral laryngoscopy endotracheal injection (LEI) of artificial seawater. We then administered mesenchymal stem cells (MSCs) via laryngoscopy endotracheal nebulized inhalation. We tested our hypotheses using pulmonary function tests, micro-computed tomography (Micro-CT), hematoxylin and eosin (HE) staining, Masson staining, immunofluorescence, immunoblotting, flow cytometry, transcriptome sequencing, quantitative real-time polymerase chain reaction (qPCR), and enzyme-linked immunosorbent assay (ELISA).

Results: We successfully established the SWD-ALI model via LEI method of seawater. The results indicated that SWD induced severe ALI by activating the Snail-mediated epithelial-mesenchymal transition (EMT) pathway through the tumor necrosis factor alpha (TNFα) inflammatory response. Further, we administered transoral laryngoscopy endotracheal nebulization to the SWD mice treated with inhaled MSCs. Non-invasive pulmonary function tests revealed that the respiratory symptoms and respiratory function of the mice were significantly alleviated. Additionally, the histological injury and air-blood barrier, and inflammatory response were significantly mitigated, and TNFα-mediated Snail expression was significantly down-regulated. Importantly, we used Masson staining to examine mouse lung tissue after 28 days of drowning and found that the SWD mice suffered from significant long-term pulmonary fibrosis injury, and MSCs treatment significantly attenuated the degree of fibrosis.

Conclusions: Our research revealed that SWD triggered severe ALI, followed by long-term pulmonary fibrosis. However, treatment with nebulized MSCs significantly mitigated the ALI and slowed the progression of fibrosis.

背景:近年来,海水溺水(SWD)的危害日益严重。它不仅会导致直接死亡,还会引起严重的并发症,如急性肺损伤(ALI),从而大大增加死亡率。因此,研究 SWD 引发肺损伤的机制并发现有效的治疗方法具有重要意义。本研究的目的是最大限度地降低 SWD-ALI 的致死率和致残率:方法:我们利用雄性 C57BL/6 小鼠,通过口腔喉镜气管内注射(LEI)人工海水,建立了 SWD 诱导 ALI(SWD-ALI)模型。然后,我们通过喉镜气管内雾化吸入间充质干细胞(MSCs)。我们使用肺功能测试、微型计算机断层扫描(Micro-CT)、苏木精和伊红(HE)染色、马森染色、免疫荧光、免疫印迹、流式细胞术、转录组测序、定量实时聚合酶链式反应(qPCR)和酶联免疫吸附试验(ELISA)来检验我们的假设:结果:我们成功地通过海水LEI法建立了SWD-ALI模型。结果:我们成功地通过海水渗入法建立了 SWD-ALI 模型,结果表明 SWD 可通过肿瘤坏死因子α(TNFα)炎症反应激活蜗牛介导的上皮-间质转化(EMT)通路,从而诱发严重的 ALI。此外,我们还对吸入间充质干细胞治疗的SWD小鼠进行了经口喉镜气管内雾化吸入。无创肺功能测试显示,小鼠的呼吸道症状和呼吸功能得到了明显缓解。此外,组织学损伤和气血屏障以及炎症反应也明显减轻,TNFα介导的蜗牛表达明显下调。重要的是,我们用Masson染色法检测了溺水28天后的小鼠肺组织,发现SWD小鼠遭受了明显的长期肺纤维化损伤,而间叶干细胞治疗可明显减轻肺纤维化程度:我们的研究发现,SWD会引发严重的ALI,继而导致长期肺纤维化。结论:我们的研究发现,SWD 会引发严重的 ALI,继而导致长期的肺纤维化,但使用雾化间充质干细胞治疗可明显减轻 ALI,并减缓肺纤维化的进展。
{"title":"Mesenchymal stem cell treatment alleviates seawater drowning induced lung injury by inhibiting the TNFα/Snail/EMT pathway.","authors":"Jinxia Liu, Lingping Zhao, Chunsun Li, Yali Jia, Zhen Yang, Zhixin Liang, Haiyang Wang, Xiuqing Ma, Chengcheng Su, Jiabo Ren, Zhenfei Mo, Wenli Liu, Peixin Wu, Yue Yin, Shangshu Liu, Wen Yue, Jiafei Xi, Liangan Chen","doi":"10.21037/jtd-24-1471","DOIUrl":"10.21037/jtd-24-1471","url":null,"abstract":"<p><strong>Background: </strong>Seawater drowning (SWD) has been an escalating hazard in recent years. It can not only cause immediate death but can also inflict severe complications, such as acute lung injury (ALI), which greatly increases the mortality rate. Thus, investigating the mechanism of SWD induced lung injury and discovering effective treatments is of great importance. The aim of this study was to minimize the lethality and disability of SWD-ALI.</p><p><strong>Methods: </strong>Using male C57BL/6 mice, we established a SWD induced ALI (SWD-ALI) model via the oral laryngoscopy endotracheal injection (LEI) of artificial seawater. We then administered mesenchymal stem cells (MSCs) via laryngoscopy endotracheal nebulized inhalation. We tested our hypotheses using pulmonary function tests, micro-computed tomography (Micro-CT), hematoxylin and eosin (HE) staining, Masson staining, immunofluorescence, immunoblotting, flow cytometry, transcriptome sequencing, quantitative real-time polymerase chain reaction (qPCR), and enzyme-linked immunosorbent assay (ELISA).</p><p><strong>Results: </strong>We successfully established the SWD-ALI model via LEI method of seawater. The results indicated that SWD induced severe ALI by activating the Snail-mediated epithelial-mesenchymal transition (EMT) pathway through the tumor necrosis factor alpha (TNFα) inflammatory response. Further, we administered transoral laryngoscopy endotracheal nebulization to the SWD mice treated with inhaled MSCs. Non-invasive pulmonary function tests revealed that the respiratory symptoms and respiratory function of the mice were significantly alleviated. Additionally, the histological injury and air-blood barrier, and inflammatory response were significantly mitigated, and TNFα-mediated Snail expression was significantly down-regulated. Importantly, we used Masson staining to examine mouse lung tissue after 28 days of drowning and found that the SWD mice suffered from significant long-term pulmonary fibrosis injury, and MSCs treatment significantly attenuated the degree of fibrosis.</p><p><strong>Conclusions: </strong>Our research revealed that SWD triggered severe ALI, followed by long-term pulmonary fibrosis. However, treatment with nebulized MSCs significantly mitigated the ALI and slowed the progression of fibrosis.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7836-7852"},"PeriodicalIF":2.1,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635247/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment and validation of a prognostic model for idiopathic pulmonary fibrosis based on mitochondrial-related genes. 基于线粒体相关基因的特发性肺纤维化预后模型的建立和验证。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-30 Epub Date: 2024-11-14 DOI: 10.21037/jtd-24-760
Xuewen Wang, Luqin Yang, Yuxuan Wang, Xinran Dou, Yonghao Li, Ke Wang, Huilan Zhang
<p><strong>Background: </strong>The prognosis for patients diagnosed with idiopathic pulmonary fibrosis (IPF) is exceedingly grim, and there are currently no pharmacological interventions available that effectively reduce mortality rates. Emerging evidence underscores the intimate connection between mitochondrial dysfunction and the onset and advancement of IPF. However, there remains a scarcity of prognostic models for assessing the risk associated with mitochondrial-related genes in IPF. This study aims to develop a comprehensive prognostic model for IPF that incorporates mitochondrial-related genes to enhance risk assessment and guide clinical decision-making.</p><p><strong>Methods: </strong>Two IPF-related microarray expression profiling datasets (GSE28042 and GSE70866) accompanied with survival data were acquired from the Gene Expression Omnibus (GEO) database. The "limma" R package was used to identify differentially expressed mitochondrial-related genes between normal samples and IPF samples. The prognostic model was constructed using univariate Cox regression, the least absolute shrinkage and selection operator (LASSO) Cox regression analyses, and multivariate Cox regression analysis. Multivariate independent prognostic analysis was conducted to ascertain whether the risk score could serve as an independent prognostic factor for predicting clinicopathological outcomes. A nomogram was employed to forecast the survival probability of IPF patients, providing valuable support for clinical decision-making processes. The CIBERSORT algorithm was utilized to examine discrepancies in immune cell infiltration within the model. The expression of genes screened from the prognostic model was validated in external data sets and western blot assays.</p><p><strong>Results: </strong>We developed a prognostic model for mitochondrial-related risks, incorporating <i>ARMCX2</i> and <i>ACOT11</i>, and subsequently validated its predictive efficacy in the validation set. The IPF samples were stratified into high-risk and low-risk groups based on the median of the risk score. According to Kaplan-Meier curve analysis, the high-risk group exhibited inferior outcomes compared to the low-risk group. The time-dependent receiver operating characteristic (ROC) analysis demonstrated the accurate prognostic capability of the risk model for IPF. A nomogram, accompanied by calibration curves, was presented to predict 1-, 2-, and 3-year survival in IPF patients. The risk model we employed not only unveiled significant disparities in functional enrichment between the high-risk and low-risk groups, but also demonstrated a robust correlation with the infiltration of specific immune cells.</p><p><strong>Conclusions: </strong>In this study, the mitochondrial-related prognostic model incorporating <i>ARMCX2</i> and <i>ACOT11</i> demonstrates potential clinical utility for informing decision-making in IPF patients and offers valuable insights for future therapeutic interventions.<
{"title":"Establishment and validation of a prognostic model for idiopathic pulmonary fibrosis based on mitochondrial-related genes.","authors":"Xuewen Wang, Luqin Yang, Yuxuan Wang, Xinran Dou, Yonghao Li, Ke Wang, Huilan Zhang","doi":"10.21037/jtd-24-760","DOIUrl":"10.21037/jtd-24-760","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The prognosis for patients diagnosed with idiopathic pulmonary fibrosis (IPF) is exceedingly grim, and there are currently no pharmacological interventions available that effectively reduce mortality rates. Emerging evidence underscores the intimate connection between mitochondrial dysfunction and the onset and advancement of IPF. However, there remains a scarcity of prognostic models for assessing the risk associated with mitochondrial-related genes in IPF. This study aims to develop a comprehensive prognostic model for IPF that incorporates mitochondrial-related genes to enhance risk assessment and guide clinical decision-making.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Two IPF-related microarray expression profiling datasets (GSE28042 and GSE70866) accompanied with survival data were acquired from the Gene Expression Omnibus (GEO) database. The \"limma\" R package was used to identify differentially expressed mitochondrial-related genes between normal samples and IPF samples. The prognostic model was constructed using univariate Cox regression, the least absolute shrinkage and selection operator (LASSO) Cox regression analyses, and multivariate Cox regression analysis. Multivariate independent prognostic analysis was conducted to ascertain whether the risk score could serve as an independent prognostic factor for predicting clinicopathological outcomes. A nomogram was employed to forecast the survival probability of IPF patients, providing valuable support for clinical decision-making processes. The CIBERSORT algorithm was utilized to examine discrepancies in immune cell infiltration within the model. The expression of genes screened from the prognostic model was validated in external data sets and western blot assays.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We developed a prognostic model for mitochondrial-related risks, incorporating &lt;i&gt;ARMCX2&lt;/i&gt; and &lt;i&gt;ACOT11&lt;/i&gt;, and subsequently validated its predictive efficacy in the validation set. The IPF samples were stratified into high-risk and low-risk groups based on the median of the risk score. According to Kaplan-Meier curve analysis, the high-risk group exhibited inferior outcomes compared to the low-risk group. The time-dependent receiver operating characteristic (ROC) analysis demonstrated the accurate prognostic capability of the risk model for IPF. A nomogram, accompanied by calibration curves, was presented to predict 1-, 2-, and 3-year survival in IPF patients. The risk model we employed not only unveiled significant disparities in functional enrichment between the high-risk and low-risk groups, but also demonstrated a robust correlation with the infiltration of specific immune cells.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;In this study, the mitochondrial-related prognostic model incorporating &lt;i&gt;ARMCX2&lt;/i&gt; and &lt;i&gt;ACOT11&lt;/i&gt; demonstrates potential clinical utility for informing decision-making in IPF patients and offers valuable insights for future therapeutic interventions.&lt;","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7427-7445"},"PeriodicalIF":2.1,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635208/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic artificial intelligence model predicts lymph node status in non-small cell lung cancer using simplified examination. 利用简化检查预测非小细胞肺癌淋巴结状态的人工智能诊断模型。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-30 Epub Date: 2024-11-18 DOI: 10.21037/jtd-24-1067
Ryuichi Yoshimura, Yoshitaka Endo, Takuya Akashi, Hiroyuki Deguchi, Makoto Tomoyasu, Wataru Shigeeda, Yuka Kaneko, Hajime Saito

Background: Artificial intelligence (AI) technology was introduced in medical data area and applied disease prediction models. This study aimed to establish an AI model for predicting lymph node metastasis based on simple medical examinations in patients with non-small cell lung cancer (NSCLC).

Methods: We retrospectively analyzed 988 patients with NSCLC who underwent radical pulmonary resection with mediastinal lymph node dissection between January 2011 and October 2022. We collected clinical characteristics including age, sex, smoking history, tumor marker levels, tumor side, segment location, total tumor size, solid tumor size and consolidation-to-tumor ratio, obtainable from medical interview, blood tests and plain computed tomography (CT) of the chest. All patients were randomly classified into a training set (n=790) and a validation set (n=198). Six algorithms including Support Vector Classification (SVC), k-nearest neighbor algorithm (k-NN), logistic regression (LR), random forest (RF), gradient boosting (GB) and multilayer perceptron (MLP) were created to decide the lymph node metastasis.

Results: The GB model showed the best diagnostic performance, with 80.0% accuracy, 95.6% specificity and an area under the curve (AUC) of 0.75.

Conclusions: An AI model showed high specificity and accuracy for predicting lymph node metastasis. These models have potential to categorize suitable surgical procedures for NSCLC patients without needing contrast-enhanced CT or positron emission tomography.

背景:人工智能(AI)技术被引入医疗数据领域并应用于疾病预测模型。本研究旨在根据非小细胞肺癌(NSCLC)患者的简单体检结果,建立预测淋巴结转移的人工智能模型:我们回顾性分析了 2011 年 1 月至 2022 年 10 月间接受根治性肺切除术并行纵隔淋巴结清扫术的 988 例 NSCLC 患者。我们收集了患者的临床特征,包括年龄、性别、吸烟史、肿瘤标志物水平、肿瘤侧位、节段位置、肿瘤总大小、实体瘤大小和合并瘤比,这些特征可通过问诊、血液检查和胸部计算机断层扫描(CT)获得。所有患者被随机分为训练集(790 人)和验证集(198 人)。研究人员创建了包括支持向量分类(SVC)、k-近邻算法(k-NN)、逻辑回归(LR)、随机森林(RF)、梯度提升(GB)和多层感知器(MLP)在内的六种算法来判定淋巴结转移:GB模型的诊断效果最好,准确率为80.0%,特异性为95.6%,曲线下面积(AUC)为0.75:人工智能模型在预测淋巴结转移方面表现出较高的特异性和准确性。这些模型有望在无需对比增强 CT 或正电子发射断层扫描的情况下,为 NSCLC 患者分类适合的手术方法。
{"title":"Diagnostic artificial intelligence model predicts lymph node status in non-small cell lung cancer using simplified examination.","authors":"Ryuichi Yoshimura, Yoshitaka Endo, Takuya Akashi, Hiroyuki Deguchi, Makoto Tomoyasu, Wataru Shigeeda, Yuka Kaneko, Hajime Saito","doi":"10.21037/jtd-24-1067","DOIUrl":"10.21037/jtd-24-1067","url":null,"abstract":"<p><strong>Background: </strong>Artificial intelligence (AI) technology was introduced in medical data area and applied disease prediction models. This study aimed to establish an AI model for predicting lymph node metastasis based on simple medical examinations in patients with non-small cell lung cancer (NSCLC).</p><p><strong>Methods: </strong>We retrospectively analyzed 988 patients with NSCLC who underwent radical pulmonary resection with mediastinal lymph node dissection between January 2011 and October 2022. We collected clinical characteristics including age, sex, smoking history, tumor marker levels, tumor side, segment location, total tumor size, solid tumor size and consolidation-to-tumor ratio, obtainable from medical interview, blood tests and plain computed tomography (CT) of the chest. All patients were randomly classified into a training set (n=790) and a validation set (n=198). Six algorithms including Support Vector Classification (SVC), k-nearest neighbor algorithm (k-NN), logistic regression (LR), random forest (RF), gradient boosting (GB) and multilayer perceptron (MLP) were created to decide the lymph node metastasis.</p><p><strong>Results: </strong>The GB model showed the best diagnostic performance, with 80.0% accuracy, 95.6% specificity and an area under the curve (AUC) of 0.75.</p><p><strong>Conclusions: </strong>An AI model showed high specificity and accuracy for predicting lymph node metastasis. These models have potential to categorize suitable surgical procedures for NSCLC patients without needing contrast-enhanced CT or positron emission tomography.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7320-7328"},"PeriodicalIF":2.1,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exacerbation of pulmonary fibrosis following acute lung injury via activin-A production by recruited alveolar macrophages. 通过招募的肺泡巨噬细胞产生活化素-A,加剧急性肺损伤后的肺纤维化。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-30 Epub Date: 2024-11-14 DOI: 10.21037/jtd-24-680
Ting Pan, Yinzhou Feng, Yufan Li, Yanping Yang, Jian Zhou, Yuanlin Song
<p><strong>Background: </strong>Acute respiratory distress syndrome (ARDS) is a complicated pathological cascade process of excessive pulmonary inflammation and alveolar epithelial cell apoptosis that results in respiratory dysfunction and failure. Some cases of ARDS can result in a more severe state of pulmonary fibrosis, referred to as postinjury lung fibrosis. The mortality and incidence rate of ARDS are high, particularly when it leads to continuing alveolar and interstitial fibrosis, which requires urgent treatment and appropriate management. The lipopolysaccharide (LPS)-induced acute lung injury (ALI) mouse model has been widely implemented for studying ARDS in humans. In our study, we found alterations in the alveolar macrophage (AM) profile in such a mouse model. Specifically, activin-A produced by dominantly recruited AMs (recAMs) was noted to be implicated in the process of post-injury lung fibrosis.</p><p><strong>Methods: </strong>The ALI animal model in C57BL/6 mice was established via 3.5 mg/kg of LPS intratracheal administration. Single-cell RNA (scRNA) sequencing was used for detailed classification and functional characterization of lung macrophages. Through <i>in vivo</i> experiments, we evaluated the role that activin-A plays in post-injury lung fibrosis in an ALI mouse model using enzyme-linked immunosorbent assay (ELISA), histological staining methods, and immunofluorescence. Through <i>in vitro</i> experiments, we analyzed the effect of activin-A on murine lung epithelial 12 (MLE-12) cells and bone marrow-derived macrophages (BMDMs) using Western blotting (WB), quantitative real-time polymerase chain reaction, RNA sequencing, and immunofluorescence.</p><p><strong>Results: </strong>Our findings revealed that recAMs replaced tissue-resident alveolar macrophages (TRAMs) as the dominant macrophage population in the setting of ALI. The results of Gene Ontology (GO) analysis suggested that activin-A was associated with wound healing and suppressor of mothers against decapentaplegic (SMAD) protein signaling pathways. Immunofluorescence results revealed that the receptor of activin-A mainly localized to alveolar epithelial cells and macrophages. Subsequently, activin-A was specifically found to drive MLE-12 cells to mesenchymal cell transformation via the transforming growth factor-β (TGF-β)/SMAD signaling. Moreover, the results of transcriptome analysis and WB confirmed that activin-A could enhance the concerted activity of Hippo and TGF-β/SMAD pathways in BMDMs, leading to an increased expression of profibrotic mediator. Moreover, yes-associated protein (YAP) and transcriptional coactivated with PDZ-binding motif (TAZ) proteins were found to drive BMDM activin-A expression, which could generate a positive feedback mechanism that perpetuates fibrosis.</p><p><strong>Conclusions: </strong>Our findings revealed that activin-A is involved in the pathological mechanisms in post-injury lung fibrosis by promoting epithelial-mesenchymal tra
{"title":"Exacerbation of pulmonary fibrosis following acute lung injury via activin-A production by recruited alveolar macrophages.","authors":"Ting Pan, Yinzhou Feng, Yufan Li, Yanping Yang, Jian Zhou, Yuanlin Song","doi":"10.21037/jtd-24-680","DOIUrl":"https://doi.org/10.21037/jtd-24-680","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Acute respiratory distress syndrome (ARDS) is a complicated pathological cascade process of excessive pulmonary inflammation and alveolar epithelial cell apoptosis that results in respiratory dysfunction and failure. Some cases of ARDS can result in a more severe state of pulmonary fibrosis, referred to as postinjury lung fibrosis. The mortality and incidence rate of ARDS are high, particularly when it leads to continuing alveolar and interstitial fibrosis, which requires urgent treatment and appropriate management. The lipopolysaccharide (LPS)-induced acute lung injury (ALI) mouse model has been widely implemented for studying ARDS in humans. In our study, we found alterations in the alveolar macrophage (AM) profile in such a mouse model. Specifically, activin-A produced by dominantly recruited AMs (recAMs) was noted to be implicated in the process of post-injury lung fibrosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The ALI animal model in C57BL/6 mice was established via 3.5 mg/kg of LPS intratracheal administration. Single-cell RNA (scRNA) sequencing was used for detailed classification and functional characterization of lung macrophages. Through &lt;i&gt;in vivo&lt;/i&gt; experiments, we evaluated the role that activin-A plays in post-injury lung fibrosis in an ALI mouse model using enzyme-linked immunosorbent assay (ELISA), histological staining methods, and immunofluorescence. Through &lt;i&gt;in vitro&lt;/i&gt; experiments, we analyzed the effect of activin-A on murine lung epithelial 12 (MLE-12) cells and bone marrow-derived macrophages (BMDMs) using Western blotting (WB), quantitative real-time polymerase chain reaction, RNA sequencing, and immunofluorescence.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Our findings revealed that recAMs replaced tissue-resident alveolar macrophages (TRAMs) as the dominant macrophage population in the setting of ALI. The results of Gene Ontology (GO) analysis suggested that activin-A was associated with wound healing and suppressor of mothers against decapentaplegic (SMAD) protein signaling pathways. Immunofluorescence results revealed that the receptor of activin-A mainly localized to alveolar epithelial cells and macrophages. Subsequently, activin-A was specifically found to drive MLE-12 cells to mesenchymal cell transformation via the transforming growth factor-β (TGF-β)/SMAD signaling. Moreover, the results of transcriptome analysis and WB confirmed that activin-A could enhance the concerted activity of Hippo and TGF-β/SMAD pathways in BMDMs, leading to an increased expression of profibrotic mediator. Moreover, yes-associated protein (YAP) and transcriptional coactivated with PDZ-binding motif (TAZ) proteins were found to drive BMDM activin-A expression, which could generate a positive feedback mechanism that perpetuates fibrosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Our findings revealed that activin-A is involved in the pathological mechanisms in post-injury lung fibrosis by promoting epithelial-mesenchymal tra","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7709-7728"},"PeriodicalIF":2.1,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precise diagnosis and prognosis assessment of malignant lung nodules: a narrative review. 恶性肺结节的精确诊断和预后评估:综述。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-30 Epub Date: 2024-11-29 DOI: 10.21037/jtd-24-1058
Miaomiao Wen, Qian Zheng, Xiaohong Ji, Shaowei Xin, Yinxi Zhou, Yahui Tian, Zitong Wan, Jiao Zhang, Jie Yang, Yongfu Ma, Yanlu Xiong

Background and objective: Pulmonary nodules (PNs) are small (≤3 cm) radiographic opacities within lung parenchyma. The use of low-dose computed tomography (LDCT) has led to a significant increase in the identification of solitary nodules. Malignant lung nodules comprise only 5% of all nodules, with management differing greatly from benign cases. Despite diagnostic advancements, there is heterogeneity in prognosis, which can result in undertreatment of high-risk patients and inappropriate treatment for low-risk patients. Therefore, accurately distinguishing benign from malignant nodules and effectively stratifying the risk of malignant nodules is a pressing clinical challenge requiring urgent resolution. The main objectives of this review were to explore the research progress in the clinical management of malignant PNs, including early detection, individualized treatment, and prognosis prediction, in order to shed light on precision medicine for patients with PNs.

Methods: The review examined various approaches for the identification and prognosis prediction of early lung cancer characterized by lung nodules, including the use of classical clinicopathological features, liquid biopsy, and artificial intelligence.

Key content and findings: The detection rate of early lung cancer characterized by lung nodules is increasing annually, and accurate identification and prognosis prediction are critical for appropriate therapeutic strategies and precise postoperative management. Classical clinicopathological features, such as demographic and radiological features, play an important role in the diagnosis and prognosis assessment of early lung cancer, but liquid biopsy and artificial intelligence are also promising due to their obvious convenience and accuracy.

Conclusions: The review highlights the importance of precision medicine in the clinical management of malignant lung nodules. The use of classical clinicopathological features, liquid biopsy, and artificial intelligence can contribute to the early detection, individualized treatment, and accurate prognosis prediction for patients with lung nodules, ultimately improving their clinical outcomes.

背景和目的:肺结节(PNs)是肺实质内的小(≤3 厘米)放射性不透明。低剂量计算机断层扫描(LDCT)的使用大大提高了单发结节的识别率。恶性肺结节仅占所有结节的 5%,其治疗方法与良性病例大相径庭。尽管诊断技术不断进步,但预后仍存在异质性,这可能导致对高危患者的治疗不足和对低危患者的治疗不当。因此,准确区分良性和恶性结节,并对恶性结节进行有效的风险分层,是临床亟待解决的难题。本综述的主要目的是探讨恶性结节临床治疗的研究进展,包括早期检测、个体化治疗和预后预测,从而为结节患者的精准医疗提供启示:方法:综述研究了以肺结节为特征的早期肺癌的识别和预后预测的各种方法,包括经典临床病理特征、液体活检和人工智能的应用:以肺部结节为特征的早期肺癌的检出率逐年上升,准确的鉴别和预后预测对于适当的治疗策略和精确的术后管理至关重要。经典的临床病理特征,如人口学和放射学特征,在早期肺癌的诊断和预后评估中发挥着重要作用,但液体活检和人工智能也因其明显的便利性和准确性而大有可为:综述强调了精准医疗在恶性肺结节临床治疗中的重要性。经典临床病理特征、液体活检和人工智能的应用有助于肺结节患者的早期发现、个体化治疗和准确预后预测,最终改善患者的临床预后。
{"title":"Precise diagnosis and prognosis assessment of malignant lung nodules: a narrative review.","authors":"Miaomiao Wen, Qian Zheng, Xiaohong Ji, Shaowei Xin, Yinxi Zhou, Yahui Tian, Zitong Wan, Jiao Zhang, Jie Yang, Yongfu Ma, Yanlu Xiong","doi":"10.21037/jtd-24-1058","DOIUrl":"10.21037/jtd-24-1058","url":null,"abstract":"<p><strong>Background and objective: </strong>Pulmonary nodules (PNs) are small (≤3 cm) radiographic opacities within lung parenchyma. The use of low-dose computed tomography (LDCT) has led to a significant increase in the identification of solitary nodules. Malignant lung nodules comprise only 5% of all nodules, with management differing greatly from benign cases. Despite diagnostic advancements, there is heterogeneity in prognosis, which can result in undertreatment of high-risk patients and inappropriate treatment for low-risk patients. Therefore, accurately distinguishing benign from malignant nodules and effectively stratifying the risk of malignant nodules is a pressing clinical challenge requiring urgent resolution. The main objectives of this review were to explore the research progress in the clinical management of malignant PNs, including early detection, individualized treatment, and prognosis prediction, in order to shed light on precision medicine for patients with PNs.</p><p><strong>Methods: </strong>The review examined various approaches for the identification and prognosis prediction of early lung cancer characterized by lung nodules, including the use of classical clinicopathological features, liquid biopsy, and artificial intelligence.</p><p><strong>Key content and findings: </strong>The detection rate of early lung cancer characterized by lung nodules is increasing annually, and accurate identification and prognosis prediction are critical for appropriate therapeutic strategies and precise postoperative management. Classical clinicopathological features, such as demographic and radiological features, play an important role in the diagnosis and prognosis assessment of early lung cancer, but liquid biopsy and artificial intelligence are also promising due to their obvious convenience and accuracy.</p><p><strong>Conclusions: </strong>The review highlights the importance of precision medicine in the clinical management of malignant lung nodules. The use of classical clinicopathological features, liquid biopsy, and artificial intelligence can contribute to the early detection, individualized treatment, and accurate prognosis prediction for patients with lung nodules, ultimately improving their clinical outcomes.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7999-8013"},"PeriodicalIF":2.1,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635230/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preliminary experience of endovascular treatment of acute mesenteric occlusion in stable patients with acute type A aortic dissection. 对急性 A 型主动脉夹层病情稳定患者进行急性肠系膜闭塞血管内治疗的初步经验。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-30 Epub Date: 2024-11-22 DOI: 10.21037/jtd-24-881
Huiyong Wang, Caiyun He, Yipeng Du, Jian Shi, Xiaolu Hu, Zheng Huang

Background: Patients presenting with Stanford type A aortic dissection complicated by acute occlusion of the superior mesenteric artery (SMA) exhibit an exceedingly high mortality rate, even if emergency surgery for ascending aorta repair is performed. consequently, appropriate management of acute SMA occlusion arising from acute Stanford type A aortic dissection is crucial. This study aimed to evaluate the safety and efficacy of endovascular treatment of acute mesenteric occlusion first in stable patients with acute type A aortic dissection.

Methods: The study was a single-center case series. Data collected from 11 consecutive patients over 12 years, from March 2010 to November 2022, were retrospectively analyzed. All were expeditiously escorted to the interventional suite via the prioritized green channel of the chest pain center and received the endovascular treatment of acute mesenteric occlusion first. Post-procedure, patients were promptly transferred to the Intensive Care Unit for close monitoring and got standardized medication. After hospital discharge, patients underwent follow-up aortic computed tomography angiography (CTA) at 1 month, 6 months, and annually thereafter to ensure continuous monitoring of the patient's condition and timely identification of any potential complications.

Results: All patients were male, with a mean age of 49.5 years. Time from abdominal distension and pain onset to admission to the catheterization laboratory was 4-13 (mean 6.9) hours. Endovascular repair of the SMA was successfully completed with uneventful hospital courses in all patients. Bowel sounds weakened in 6 cases and disappeared in 5, while bloody stools occurred in 3 without intestinal necrosis. At 2-32 months follow-up, the patients had no abdominal pain, distension nor other signs of mesenteric artery ischemia.

Conclusions: For patients with acute SMA occlusion caused by acute Stanford type A aortic dissection, endovascular treatment first to restore blood supply to the SMA appears feasible, safe and efficacious.

背景:因肠系膜上动脉(SMA)急性闭塞而并发斯坦福A型主动脉夹层的患者死亡率极高,即使进行了升主动脉修复急诊手术也是如此。本研究旨在评估急性 A 型主动脉夹层病情稳定患者首先接受急性肠系膜闭塞血管内治疗的安全性和有效性:该研究是一项单中心病例系列研究。方法:该研究为单中心病例系列,对 2010 年 3 月至 2022 年 11 月的 12 年间连续 11 例患者的数据进行了回顾性分析。所有患者均通过胸痛中心的优先绿色通道被迅速护送至介入室,首先接受急性肠系膜闭塞的血管内治疗。术后,患者被迅速转入重症监护室,接受严密监护和规范用药。出院后,患者分别在1个月、6个月和以后每年接受一次主动脉计算机断层扫描(CTA)随访,以确保持续监测患者病情并及时发现任何潜在并发症:所有患者均为男性,平均年龄为 49.5 岁。从腹胀和疼痛发作到入住导管室的时间为 4-13 小时(平均 6.9 小时)。所有患者均顺利完成了 SMA 的血管内修复手术,住院期间一切顺利。6例肠鸣音减弱,5例消失,3例出现血便,但无肠坏死。在 2-32 个月的随访中,患者没有腹痛、腹胀或其他肠系膜动脉缺血的症状:结论:对于由急性斯坦福A型主动脉夹层引起的急性SMA闭塞患者,首先进行血管内治疗以恢复SMA的血液供应似乎是可行、安全和有效的。
{"title":"Preliminary experience of endovascular treatment of acute mesenteric occlusion in stable patients with acute type A aortic dissection.","authors":"Huiyong Wang, Caiyun He, Yipeng Du, Jian Shi, Xiaolu Hu, Zheng Huang","doi":"10.21037/jtd-24-881","DOIUrl":"10.21037/jtd-24-881","url":null,"abstract":"<p><strong>Background: </strong>Patients presenting with Stanford type A aortic dissection complicated by acute occlusion of the superior mesenteric artery (SMA) exhibit an exceedingly high mortality rate, even if emergency surgery for ascending aorta repair is performed. consequently, appropriate management of acute SMA occlusion arising from acute Stanford type A aortic dissection is crucial. This study aimed to evaluate the safety and efficacy of endovascular treatment of acute mesenteric occlusion first in stable patients with acute type A aortic dissection.</p><p><strong>Methods: </strong>The study was a single-center case series. Data collected from 11 consecutive patients over 12 years, from March 2010 to November 2022, were retrospectively analyzed. All were expeditiously escorted to the interventional suite via the prioritized green channel of the chest pain center and received the endovascular treatment of acute mesenteric occlusion first. Post-procedure, patients were promptly transferred to the Intensive Care Unit for close monitoring and got standardized medication. After hospital discharge, patients underwent follow-up aortic computed tomography angiography (CTA) at 1 month, 6 months, and annually thereafter to ensure continuous monitoring of the patient's condition and timely identification of any potential complications.</p><p><strong>Results: </strong>All patients were male, with a mean age of 49.5 years. Time from abdominal distension and pain onset to admission to the catheterization laboratory was 4-13 (mean 6.9) hours. Endovascular repair of the SMA was successfully completed with uneventful hospital courses in all patients. Bowel sounds weakened in 6 cases and disappeared in 5, while bloody stools occurred in 3 without intestinal necrosis. At 2-32 months follow-up, the patients had no abdominal pain, distension nor other signs of mesenteric artery ischemia.</p><p><strong>Conclusions: </strong>For patients with acute SMA occlusion caused by acute Stanford type A aortic dissection, endovascular treatment first to restore blood supply to the SMA appears feasible, safe and efficacious.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7342-7349"},"PeriodicalIF":2.1,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of thoracic disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1